Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) Debt to equity
Bruker Corporation's debt to equity at the end of the quarter to 30 September 2026 was 0.7×, down 0.0× from fiscal 2025 (0.8×). Over the past ten years it has ranged from 0.4× (fiscal 2015) to 1.2× (fiscal 2021); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.8× | (35.16%) |
| FY2024 | 1.2× | 26.83% |
| FY2023 | 0.9× | (15.16%) |
| FY2022 | 1.1× | (11.95%) |
| FY2021 | 1.2× | 41.91% |
| FY2020 | 0.9× | (2.26%) |
| FY2019 | 0.9× | 135.29% |
| FY2018 | 0.4× | (33.48%) |
| FY2017 | 0.6× | (4.61%) |
| FY2016 | 0.6× | 63.77% |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.7× | (2.28%) |
| Jun 2026 | 0.8× | 12.22% |
| Mar 2026 | 0.7× | (10.34%) |
| Dec 2025 | 0.8× | (7.85%) |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GMED Globus Medical, Inc. compare | 0.0× |
| TXG 10x Genomics compare | 0.0× |
| PEN Penumbra, Inc. compare | 0.0× |
| GKOS Glaukos Corporation compare | 0.1× |
| BIO Bio-Rad Laboratories, Inc. compare | 0.2× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.2× |
| PODD Insulet Corporation compare | 0.6× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.6× |
| BRKR Bruker Corporation | 0.7× |
| Medical Devices industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement